Plymouth Oncology Centre, Derriford Hospital, and Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom (M.S.H.); Department of Animal Physiology and Neurobiology (B.L.) and Laboratory for Experimental Oncology (E.A.D.B.), University of Leuven, Leuven, Belgium; Oncology Department, University Hospital Antwerp, Edegem, Belgium (H.P.); and London Oncology Clinic, London, United Kingdom (P.G.H.)
Plymouth Oncology Centre, Derriford Hospital, and Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom (M.S.H.); Department of Animal Physiology and Neurobiology (B.L.) and Laboratory for Experimental Oncology (E.A.D.B.), University of Leuven, Leuven, Belgium; Oncology Department, University Hospital Antwerp, Edegem, Belgium (H.P.); and London Oncology Clinic, London, United Kingdom (P.G.H.).
Pharmacol Rev. 2022 Jul;74(3):552-599. doi: 10.1124/pharmrev.120.000121.
The nitrogen mustards are powerful cytotoxic and lymphoablative agents and have been used for more than 60 years. They are employed in the treatment of cancers, sarcomas, and hematologic malignancies. Cyclophosphamide, the most versatile of the nitrogen mustards, also has a place in stem cell transplantation and the therapy of autoimmune diseases. Adverse effects caused by the nitrogen mustards on the central nervous system, kidney, heart, bladder, and gonads remain important issues. Advances in analytical techniques have facilitated the investigation of the pharmacokinetics of the nitrogen mustards, especially the oxazaphosphorines, which are prodrugs requiring metabolic activation. Enzymes involved in the metabolism of cyclophosphamide and ifosfamide are very polymorphic, but a greater understanding of the pharmacogenomic influences on their activity has not yet translated into a personalized medicine approach. In addition to damaging DNA, the nitrogen mustards can act through other mechanisms, such as antiangiogenesis and immunomodulation. The immunomodulatory properties of cyclophosphamide are an area of current exploration. In particular, cyclophosphamide decreases the number and activity of regulatory T cells, and the interaction between cyclophosphamide and the intestinal microbiome is now recognized as an important factor. New derivatives of the nitrogen mustards continue to be assessed. Oxazaphosphorine analogs have been synthesized in attempts to both improve efficacy and reduce toxicity, with varying degrees of success. Combinations of the nitrogen mustards with monoclonal antibodies and small-molecule targeted agents are being evaluated. SIGNIFICANCE STATEMENT: The nitrogen mustards are important, well-established therapeutic agents that are used to treat a variety of diseases. Their role is continuing to evolve.
氮芥类药物是一种强大的细胞毒性和淋巴清除剂,已经使用了 60 多年。它们被用于治疗癌症、肉瘤和血液系统恶性肿瘤。环磷酰胺是氮芥类药物中用途最广泛的一种,在干细胞移植和自身免疫性疾病的治疗中也有一席之地。氮芥类药物对中枢神经系统、肾脏、心脏、膀胱和性腺的不良反应仍然是一个重要问题。分析技术的进步促进了对氮芥类药物,特别是前体药物需要代谢激活的氧氮磷杂环类药物的药代动力学的研究。参与环磷酰胺和异环磷酰胺代谢的酶非常多态性,但对其活性的药物基因组学影响的更深入理解尚未转化为个性化医疗方法。氮芥类药物除了破坏 DNA 外,还可以通过其他机制发挥作用,如抗血管生成和免疫调节。环磷酰胺的免疫调节特性是当前探索的一个领域。特别是,环磷酰胺可以降低调节性 T 细胞的数量和活性,并且环磷酰胺与肠道微生物组的相互作用现在被认为是一个重要因素。氮芥类药物的新衍生物仍在不断评估中。氧氮磷杂环类药物的合成尝试旨在提高疗效和降低毒性,取得了不同程度的成功。氮芥类药物与单克隆抗体和小分子靶向药物的联合应用正在评估中。
氮芥类药物是一种重要的、成熟的治疗药物,用于治疗多种疾病。它们的作用在不断演变。